日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis

菲戈替尼在类风湿性关节炎治疗中显示出疗效,且不受吸烟状况的影响:3期临床试验的事后分析和基于索赔数据的分析

Curtis, Jeffrey R; Emery, Paul; Downie, Bryan; Zhong, Yan; Liu, Jinfeng; Han, Ling; Hawtin, Rachael E; Burmester, Gerd Rüdiger

Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis

基线中性粒细胞与淋巴细胞比值高的患者对菲尔戈替尼治疗类风湿性关节炎的反应更好

Taylor, Peter C; Downie, Bryan; Han, Ling; Hawtin, Rachael; Hertz, Angie; Moots, Robert J; Takeuchi, Tsutomu

Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity

细胞因子诱导的JAK/STAT信号通路减弱与类风湿性关节炎及其疾病活动性相关。

Ptacek, Jason; Hawtin, Rachael E; Sun, Dongmei; Louie, Brent; Evensen, Erik; Mittleman, Barbara B; Cesano, Alessandra; Cavet, Guy; Bingham, Clifton O 3rd; Cofield, Stacey S; Curtis, Jeffrey R; Danila, Maria I; Raman, Chander; Furie, Richard A; Genovese, Mark C; Robinson, William H; Levesque, Marc C; Moreland, Larry W; Nigrovic, Peter A; Shadick, Nancy A; O'Dell, James R; Thiele, Geoffrey M; Clair, E William St; Striebich, Christopher C; Hale, Matthew B; Khalili, Houman; Batliwalla, Franak; Aranow, Cynthia; Mackay, Meggan; Diamond, Betty; Nolan, Garry P; Gregersen, Peter K; Bridges, S Louis Jr

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials.

JAK1 抑制剂 Filgotinib 可调节类风湿性关节炎的疾病相关生物标志物:两项随机对照 2b 期试验的结果

Tarrant Jacqueline M, Galien René, Li Wanying, Goyal Lovely, Pan Yang, Hawtin Rachael, Zhang Wangshu, Van der Aa Annegret, Taylor Peter C

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation

癌症免疫疗法疗效预测生物标志物的验证:第一卷——分析前验证和分析验证

Masucci, Giuseppe V; Cesano, Alessandra; Hawtin, Rachael; Janetzki, Sylvia; Zhang, Jenny; Kirsch, Ilan; Dobbin, Kevin K; Alvarez, John; Robbins, Paul B; Selvan, Senthamil R; Streicher, Howard Z; Butterfield, Lisa H; Thurin, Magdalena

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations

癌症免疫疗法疗效预测生物标志物的验证:第二卷——临床验证和监管考量

Dobbin, Kevin K; Cesano, Alessandra; Alvarez, John; Hawtin, Rachael; Janetzki, Sylvia; Kirsch, Ilan; Masucci, Giuseppe V; Robbins, Paul B; Selvan, Senthamil R; Streicher, Howard Z; Zhang, Jenny; Butterfield, Lisa H; Thurin, Magdalena

Combination immunotherapy: Where do we go from here?

联合免疫疗法:我们下一步该怎么做?

Hawtin, Rachael E; Cesano, Alessandra; Overacre, Abigail E; Kurtulus, Sema; Sznol, Mario; Pardoll, Drew M; Anderson, Ana; Vignali, Dario A A

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病患者的vosaroxin联合阿糖胞苷的1b/2期研究

Lancet, Jeffrey E; Roboz, Gail J; Cripe, Larry D; Michelson, Glenn C; Fox, Judith A; Leavitt, Richard D; Chen, Tianling; Hawtin, Rachael; Craig, Adam R; Ravandi, Farhad; Maris, Michael B; Stuart, Robert K; Karp, Judith E

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes

慢性淋巴细胞白血病和正常B淋巴细胞中IL-17F表达模式和信号通路的鉴定和表征

Sherry, Barbara; Jain, Preetesh; Chiu, Pui Yan; Leung, Ling; Allen, Steven L; Kolitz, Jonathan E; Rai, Kanti R; Barrientos, Jacquie; Liang, Spencer; Hawtin, Rachael; Chiorazzi, Nicholas

High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors

衰老免疫系统的高维分析:验证健康供体中与年龄相关的免疫信号反应差异

Longo, Diane M; Louie, Brent; Ptacek, Jason; Friedland, Greg; Evensen, Erik; Putta, Santosh; Atallah, Michelle; Spellmeyer, David; Wang, Ena; Pos, Zoltan; Marincola, Francesco M; Schaeffer, Andrea; Lukac, Suzanne; Railkar, Radha; Beals, Chan R; Cesano, Alessandra; Carayannopoulos, Leonidas N; Hawtin, Rachael E